2022 ASCRS Annual Meeting
Satellite CME Programs
The Glaucoma Treatment Spectrum: Meds, Sustained Delivery, and MIGS
PARTICIPATE AND CLAIM CME AT YOUR CONVENIENCE
This program is designed as a compact review of key surgical and therapeutic glaucoma treatments. Faculty will explore the various considerations for MIGS, to include standalone and next-generation devices and provide the latest details on glaucoma medical therapy. The program will include live panel discussion and Q&A by our expert faculty.
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from:
AbbVie
Glaukos
Mati Therapeutics
Sight Sciences
Activity Agenda
Welcoming Remarks
Leon W. Herndon, MD and Nathan M. Radcliffe, MD, ABO
Update of Latest Sustained Delivery Glaucoma Meds
Jacob W. Brubaker, MD
Presbyopia 2022: New Use for an Old Med
Sahar Bedrood, MD, PhD, ABO
Brief Overview of MIGS Choices
Won I Kim, MD, ABO
Next-Generation MIGS
Thomas D. Patrianakos, DO
Program Chairs
Leon W. Herndon, MD
Nathan Radcliffe, MD
Faculty
Jacob Brubaker. MD
Sahar Bedrood, MD
Won Kim, MD
